title: Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa.
abstract: The formation of a Pseudomonas aeruginosa biofilm, a complex structure enclosing bacterial cells in an extracellular polymeric matrix, is responsible for persistent infections in cystic fibrosis patients leading to a high rate of morbidity and mortality. The protective environment created by the tridimensional structure reduces the susceptibility of the bacteria to conventional antibiotherapy. Cationic steroid antibiotics (CSA)-13, a nonpeptide mimic of antimicrobial peptides with antibacterial activity on planktonic cultures, was evaluated for its ability to interact with sessile cells. Using confocal laser scanning microscopy, we demonstrated that the drug damaged bacteria within an established biofilm showing that penetration did not limit the activity of this antimicrobial agent against a biofilm. When biofilms were grown during exposure to shear forces and to a continuous medium flow allowing the development of robust structures with a complex architecture, CSA-13 reached the bacteria entrapped in the biofilm within 30 min. The permeabilizing effect of CSA-13 could be associated with the death of the bacteria. In static conditions, the compound did not perturb the architecture of the biofilm. This study confirms the potential of CSA-13 as a new strategy to combat persistent infections involving biofilms formed by P. aeruginosa.
authors: Laboratoire de Chimie biologique et Médicale et de Microbiologie Pharmaceutique, Faculté de Pharmacie, Université libre de Bruxelles, Brussels, Belgium.
authors: Carole
authors: C
authors: Nagant
authors: Betsey
authors: B
authors: Pitts
authors: Philip S
authors: PS
authors: Stewart
authors: Yanshu
authors: Y
authors: Feng
authors: Paul B
authors: PB
authors: Savage
authors: Jean-Paul
authors: JP
authors: Dehaye
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects* / Q000254:growth & development; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D018613:Microscopy, Confocal; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development; D013256:Steroids / Q000494:pharmacology*
chemical_list: D000890:Anti-Infective Agents; D013256:Steroids; C521528:ceragenin CSA-13